Log in or Sign up for Free to view tailored content for your specialty!
Allergy/Asthma
FDA reapproves OTC Primatene Mist for mild asthma
The FDA has approved over-the-counter Primatene Mist to temporarily relieve symptoms of mild, intermittent asthma in patients aged 12 years and older, according to a press release.
Computer-generated phone calls slightly increase asthma medication adherence
Computer-generated phone calls based on a patient’s electronic health record and answers to questions led to a small but statistically significant increase in patients with asthma taking their medications, according to findings recently published in The Journal of Allergy and Clinical Immunology: In Practice.
Log in or Sign up for Free to view tailored content for your specialty!
Epinephrine autoinjectors not used in nearly 80% of anaphylactic events
ORLANDO, Fla. — Many parents of children who require allergy treatment with epinephrine autoinjectors do not regularly use the product during an anaphylactic event, according to research presented at the AAP National Conference & Exhibition. A significant number of these parents were too scared or emotional to administer the potentially life-saving drug when needed, researchers said.
FDA considers food labeling requirements for sesame products
The FDA is requesting information regarding the prevalence of sesame allergies in the United States to determine whether the product should be mandatorily declared as an allergen on food labels. Currently, only the eight major food allergens — milk, eggs, fish, shellfish, tree nuts, peanuts, wheat and soybeans — are required to be declared on food products by federal law.
Air pollution causes millions of asthma-related ED visits around the world
At least 14 million asthma-related ED visits around the world are caused by air pollution, according to research published in Environmental Health Perspectives. A significant amount of the pollution is generated by humans, researchers wrote.
Making the case for pharmacist-administered penicillin skin test
Experts have suggested a bigger role for pharmacists in penicillin skin testing, writing in Clinical Infectious Diseases that it would expand access to the service and be good for antimicrobial stewardship efforts.
FDA approves additional Xolair formulations
The FDA has approved 75 mg/0.5 mL and 150 mg/1 mL single-dose prefilled syringes of Xolair as additional formulations for patients with allergic asthma and chronic idiopathic urticaria, according to press releases from Genentech and Novartis.
Following asthma guidelines offsets negative impact of dogs, cats, secondhand smoke
Removing dogs, cats and secondhand smoke from the homes of patients with asthma may not be necessary if certain asthma guidelines are followed, according to a study being presented later this month at CHEST 2018.
Ongoing EpiPen shortage not cause for serious alarm
The ongoing shortage of EpiPen supply — now entering its fifth month — has intersected with the high demand for auto-injectors when children return to school.
NIH, Children's National Health System join forces to study pediatric disease
In a collaborative effort between the National Institute of Allergy and Infectious Diseases at the NIH and the Children’s National Health System in Washington D.C., the institutions established a partnership to promote research on pediatric allergic, infectious, autoinflammatory and immunologic disease. The partnership, established in 2017, met today at a symposium highlighting their current and upcoming research.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read